1 insiders reported 19 Form 4 transactions for CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) over the past 18 months (most recent 2025-12-17). Recent activity: CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) Buy 8,300 shares, CTT PHARMACEUTICAL HOLDINGS, INC. (Director) Buy 200,000 shares, CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) Buy 62,900 shares, CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) Buy 7,000 shares, CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) Buy 6,815 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-17 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 8,300 | $498 |
| 2025-11-24 | CTT PHARMACEUTICAL HOLDINGS, INC. | Director | Buy | 200,000 | $8,000 |
| 2025-11-21 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 62,900 | $2,516 |
| 2025-10-31 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 7,000 | $420 |
| 2025-10-07 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 6,815 | $409 |
| 2025-09-23 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 750,000 | $30,000 |
| 2025-09-23 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 44,085 | $2,204 |
| 2025-08-01 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 15,800 | $632 |
| 2025-07-08 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 8,000 | $240 |
| 2025-06-30 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 39,600 | $1,188 |
| 2025-06-23 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 16,100 | $483 |
| 2025-06-13 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 54,798 | $1,644 |
| 2025-06-09 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 82,158 | $4,108 |
| 2025-06-09 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 150,000 | $9,000 |
| 2025-04-10 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 9,984 | $699 |
| 2025-03-31 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 15,510 | $776 |
| 2025-03-14 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 5,400 | $324 |
| 2025-03-10 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 11,950 | $1,076 |
| 2025-02-06 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 5,200 | $624 |
Source: SEC Form 4 filings · as of 2025-12-17